在患有德拉维特综合征的儿童和青少年中Zorevunersen
Linda Laux1, Joseph Sullivan2, M Scott Perry3
1From the Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago.
The New England journal of medicine
|March 4, 2026
概括
佐雷文森在治疗德拉维特综合征方面表现有前途,显著降低了发作频率,改善了患者的生活质量. 进一步的开发得到了其安全性和初始临床益处的支持.
科学领域:
- 神经学 神经学
- 遗传学 遗传学 是一个
- 药理学 药理学是指药理学的学科.
背景情况:
- 德拉维特综合征是一种严重的脑病,与SCN1A基因突变有关.
- 患者面临SUDEP和认知障碍的高风险.
- 对于德拉维特综合征,雷文森的治疗潜力以前是未知的.
研究的目的:
- 评估zorevunersen在患有德拉维特综合征的儿科患者的安全性和有效性.
- 为了评估zorevunersen的药理动力学概况.
- 探索佐雷文森对发作频率和整体幸福感的临床影响.
主要方法:
- 两项开放标签,第1-2a期研究 (MONARCH,ADMIRAL) 招募了81名2-18岁的患者.
- 佐雷文森 (Zorevunersen) 用于单次或多次上升剂量,持续3个月.
- 患者可以在延伸研究 (SWALLOWTAIL,LONGWING) 中继续治疗长达36个月.
主要成果:
- 大多数不良事件是轻度至中度的;常见事件包括腰部刺痛后综合征和CSF蛋白质升高.
- 接受70毫克佐雷文森的患者显示,发作频率的中位数减少,从-58.82%降至-90.91%.
- 持续治疗表明临床状态,生活质量和适应性行为有所改善.
结论:
- 佐雷文森在患有德拉维特综合征的患者中表现出良好的安全性.
- 最初的临床改善表明zorevunersen作为一种疾病修饰疗法的潜力.
- 对于治疗德拉维特综合征的雷文森的进一步开发是有必要的.
更多相关视频
08:30Author Spotlight: Exploring Autism Spectrum Disorder Symptoms in Fruit Flies — Genetic Models and Behavioral Tests
Published on: September 6, 2024
2.8K
05:52Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
15.6K
相关概念视频
01:19Autism Spectrum Disorder
1.4K
Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
1.4K
01:30Oppositional Defiant Disorder
1.0K
A persistent pattern of angry or irritable mood, defiant behavior, or vindictiveness characterizes Oppositional Defiant Disorder (ODD). Symptoms must occur over at least six months, involve interactions with individuals beyond siblings, and meet specific diagnostic criteria to be clinically significant. The disorder affects emotional regulation, social interactions, and behavior, often manifesting early in life and influencing long-term development and functioning.
Diagnostic Criteria and...
Diagnostic Criteria and...
1.0K
01:30Attention-Deficit/Hyperactivity Disorder
1.1K
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.1K
01:28Conduct Disorder
729
Conduct disorder is a complex mental health diagnosis characterized by a repetitive and persistent pattern of behavior that violates societal norms, the rights of others, or age-appropriate rules. The diagnostic criteria for conduct disorder require the presence of at least three problematic behaviors within the past 12 months, with at least one occurring in the past six months. These behaviors are grouped into four categories: aggression toward people and animals; destruction of property;...
729
01:43Sex-linked Disorders
110.0K
Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
110.0K
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
303
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
303